As of the latest SEC filings, BioXcel Therapeutics, Inc. (BTAIQ) is held by 8 institutional funds. The largest fund shareholder is VANGUARD EXTENDED MARKET INDEX FUND (VEMPX), holding an estimated $277,834.26 in market value, representing a significant portion of its portfolio.
Funds holding BioXcel Therapeutics, Inc. (BTAIQ)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BTAIQ
- CIK:
- 0001720893
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $277,834.26 | 207,339 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $176,240.11 | 105,533 | Feb 28, 2026 | Apr 24, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.00% | $150,801.00 | 90,300 | Feb 28, 2026 | Apr 24, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $57,175.79 | 34,237 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $44,438.70 | 26,610 | Feb 28, 2026 | Apr 24, 2026 |
|
-
Oaktree Diversified Income Fund Inc.
|
CEF | Independent / Boutique | 0.00% | $4,766.38 | 3,557 | Mar 31, 2026 | May 29, 2026 |
|
JAFEX
Total Stock Market Index Trust
|
MF | John Hancock | 0.00% | $585.58 | 437 | Mar 31, 2026 | May 29, 2026 |
|
BXMYX
Blackstone Alternative Multi-Strategy Fund
|
MF | Independent / Boutique | 0.00% | -$11,597.70 | -8,655 | Mar 31, 2026 | May 27, 2026 |
Advertisement (320x50)